Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Quantifying the Benefits of Targeting for Pandemic Response

Sergio Camelo, View ORCID ProfileFlorin Ciocan, View ORCID ProfileDan A. Iancu, View ORCID ProfileXavier S. Warnes, View ORCID ProfileSpyros I. Zoumpoulis
doi: https://doi.org/10.1101/2021.03.23.21254155
Sergio Camelo
1Institute for Computational and Mathematical Engineering, Stanford University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Florin Ciocan
2Technology and Operations Management, INSEAD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Florin Ciocan
Dan A. Iancu
3Technology and Operations Management, INSEAD and Operations, Information & Technology, Graduate School of Business, Stanford University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Dan A. Iancu
  • For correspondence: daniancu{at}stanford.edu
Xavier S. Warnes
4Operations, Information & Technology, Graduate School of Business, Stanford University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Xavier S. Warnes
Spyros I. Zoumpoulis
5Decision Sciences, INSEAD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Spyros I. Zoumpoulis
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Article Information

doi 
https://doi.org/10.1101/2021.03.23.21254155
History 
  • December 15, 2021.

Article Versions

  • Version 1 (March 26, 2021 - 11:00).
  • Version 2 (April 2, 2021 - 14:06).
  • Version 3 (June 18, 2021 - 00:06).
  • You are currently viewing Version 4 of this article (December 15, 2021 - 23:56).
  • Version 5 (November 29, 2022 - 13:31).
  • View Version 6, the most recent version of this article.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.

Author Information

  1. Sergio Camelo1,
  2. Florin Ciocan2,
  3. Dan A. Iancu3,*,
  4. Xavier S. Warnes4 and
  5. Spyros I. Zoumpoulis5
  1. 1Institute for Computational and Mathematical Engineering, Stanford University
  2. 2Technology and Operations Management, INSEAD
  3. 3Technology and Operations Management, INSEAD and Operations, Information & Technology, Graduate School of Business, Stanford University
  4. 4Operations, Information & Technology, Graduate School of Business, Stanford University
  5. 5Decision Sciences, INSEAD
  1. ↵*Corresponding author; email: daniancu{at}stanford.edu
Back to top
PreviousNext
Posted December 15, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Quantifying the Benefits of Targeting for Pandemic Response
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Quantifying the Benefits of Targeting for Pandemic Response
Sergio Camelo, Florin Ciocan, Dan A. Iancu, Xavier S. Warnes, Spyros I. Zoumpoulis
medRxiv 2021.03.23.21254155; doi: https://doi.org/10.1101/2021.03.23.21254155
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Quantifying the Benefits of Targeting for Pandemic Response
Sergio Camelo, Florin Ciocan, Dan A. Iancu, Xavier S. Warnes, Spyros I. Zoumpoulis
medRxiv 2021.03.23.21254155; doi: https://doi.org/10.1101/2021.03.23.21254155

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (576)
  • Allergy and Immunology (867)
  • Anesthesia (306)
  • Cardiovascular Medicine (4480)
  • Dentistry and Oral Medicine (449)
  • Dermatology (385)
  • Emergency Medicine (614)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1528)
  • Epidemiology (15276)
  • Forensic Medicine (31)
  • Gastroenterology (1133)
  • Genetic and Genomic Medicine (6643)
  • Geriatric Medicine (671)
  • Health Economics (1006)
  • Health Informatics (4602)
  • Health Policy (1378)
  • Health Systems and Quality Improvement (1622)
  • Hematology (544)
  • HIV/AIDS (1275)
  • Infectious Diseases (except HIV/AIDS) (15959)
  • Intensive Care and Critical Care Medicine (1110)
  • Medical Education (626)
  • Medical Ethics (147)
  • Nephrology (674)
  • Neurology (6692)
  • Nursing (346)
  • Nutrition (1006)
  • Obstetrics and Gynecology (1152)
  • Occupational and Environmental Health (961)
  • Oncology (3369)
  • Ophthalmology (988)
  • Orthopedics (370)
  • Otolaryngology (421)
  • Pain Medicine (437)
  • Palliative Medicine (131)
  • Pathology (668)
  • Pediatrics (1703)
  • Pharmacology and Therapeutics (699)
  • Primary Care Research (717)
  • Psychiatry and Clinical Psychology (5494)
  • Public and Global Health (9284)
  • Radiology and Imaging (2223)
  • Rehabilitation Medicine and Physical Therapy (1375)
  • Respiratory Medicine (1201)
  • Rheumatology (598)
  • Sexual and Reproductive Health (720)
  • Sports Medicine (535)
  • Surgery (720)
  • Toxicology (100)
  • Transplantation (290)
  • Urology (266)